-1722511478674.svg){kind=small}
Published 16:39 IST, July 11th 2024
Pfizer advances once-daily weight loss pill Danuglipron to clinical trials
The drugmaker had previously shifted its focus to developing danuglipron after discontinuing a separate, once-daily pill due to liver safety concerns.
Top 10 Pharmaceutical Companies in India by Market Capitalisation | Image:
Unsplash
- Listen to this article
- 1 min read
Advertisement
16:39 IST, July 11th 2024